It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Decline in cognitive function is the most feared aspect of ageing. Poorer midlife cognitive function is associated with increased dementia and stroke risk. The mechanisms underlying variation in cognitive function are uncertain. Here, we assessed associations between 1160 proteins’ plasma levels and two measures of cognitive function, the digit symbol substitution test (DSST) and the Montreal Cognitive Assessment in 1198 PURE-MIND participants. We identified five DSST performance-associated proteins (NCAN, BCAN, CA14, MOG, CDCP1), with NCAN and CDCP1 showing replicated association in an independent cohort, GS (N = 1053). MRI-assessed structural brain phenotypes partially mediated (8–19%) associations between NCAN, BCAN, and MOG, and DSST performance. Mendelian randomisation analyses suggested higher CA14 levels might cause larger hippocampal volume and increased stroke risk, whilst higher CDCP1 levels might increase intracranial aneurysm risk. Our findings highlight candidates for further study and the potential for drug repurposing to reduce the risk of stroke and cognitive decline.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details














1 Hamilton Health Sciences and McMaster University, Population Health Research Institute, Hamilton, Canada (GRID:grid.413615.4) (ISNI:0000 0004 0408 1354); University of Exeter, School of Psychology, Exeter, UK (GRID:grid.8391.3) (ISNI:0000 0004 1936 8024); The University of Edinburgh, Centre for Clinical Brain Sciences, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988)
2 Hamilton Health Sciences and McMaster University, Population Health Research Institute, Hamilton, Canada (GRID:grid.413615.4) (ISNI:0000 0004 0408 1354); McMaster University, Department of Pathology and Molecular Medicine, Faculty of Health Sciences, Hamilton, Canada (GRID:grid.25073.33) (ISNI:0000 0004 1936 8227)
3 Hamilton Health Sciences and McMaster University, Population Health Research Institute, Hamilton, Canada (GRID:grid.413615.4) (ISNI:0000 0004 0408 1354)
4 Hamilton Health Sciences and McMaster University, Population Health Research Institute, Hamilton, Canada (GRID:grid.413615.4) (ISNI:0000 0004 0408 1354); McMaster University, Department of Medicine, Michael G DeGroote School of Medicine, Faculty of Health Sciences, Hamilton, Canada (GRID:grid.25073.33) (ISNI:0000 0004 1936 8227)
5 University of Edinburgh, Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988)
6 The University of Edinburgh, Centre for Clinical Brain Sciences, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988)
7 University of Oxford, Department of Psychiatry, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948); Nxera Pharma UK Limited, Cambridge, UK (GRID:grid.4991.5)
8 University of Edinburgh, Generation Scotland, Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988)
9 The University of Edinburgh, Centre for Clinical Brain Sciences, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988); University of Edinburgh, Generation Scotland, Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988)
10 Nxera Pharma UK Limited, Cambridge, UK (GRID:grid.4305.2)
11 R&D, Bayer AG, Pharmaceuticals, Wuppertal, Germany (GRID:grid.420044.6) (ISNI:0000 0004 0374 4101)
12 Hamilton Health Sciences and McMaster University, Population Health Research Institute, Hamilton, Canada (GRID:grid.413615.4) (ISNI:0000 0004 0408 1354); University of Galway, Health Research Board Clinical Research Facility, Galway, Ireland (GRID:grid.6142.1) (ISNI:0000 0004 0488 0789)
13 Hamilton Health Sciences and McMaster University, Population Health Research Institute, Hamilton, Canada (GRID:grid.413615.4) (ISNI:0000 0004 0408 1354); Cumming School of Medicine, Department of Clinical Neurosciences and Hotchkiss Brain Institute, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697); University of Calgary, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697); University of Calgary, Department of Clinical Neurosciences, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697)
14 Hamilton Health Sciences and McMaster University, Population Health Research Institute, Hamilton, Canada (GRID:grid.413615.4) (ISNI:0000 0004 0408 1354); The University of Edinburgh, Centre for Clinical Brain Sciences, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988); University of Oxford, MRC Centre for Population Health, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)
15 Hamilton Health Sciences and McMaster University, Population Health Research Institute, Hamilton, Canada (GRID:grid.413615.4) (ISNI:0000 0004 0408 1354); McMaster University, Department of Pathology and Molecular Medicine, Faculty of Health Sciences, Hamilton, Canada (GRID:grid.25073.33) (ISNI:0000 0004 1936 8227); Hamilton Health Sciences and McMaster University, Thrombosis and Atherosclerosis Research Institute, Hamilton, Canada (GRID:grid.413615.4) (ISNI:0000 0004 0408 1354)